Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-30
2007-10-30
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S211060, C514S212070, C514S235800, C514S313000, C514S314000, C514S326000, C514S341000, C514S368000, C540S523000, C544S139000, C546S274400, C546S297000, C546S175000, C546S171000, C546S017000, C546S208000, C546S159000, C548S301100, C548S155000
Reexamination Certificate
active
10546889
ABSTRACT:
The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
REFERENCES:
patent: 4772632 (1988-09-01), Vistica
patent: 6548505 (2003-04-01), Martin et al.
Bell Ian M.
Gallicchio Steven N.
Stump Craig A.
Zartman C. Blair
Anderson Rebecca
Krovatin William
Merck & Co Inc.
Nolan Jason M
Todaro John C.
LandOfFree
Carboxamide spirohydantoin CGRP receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboxamide spirohydantoin CGRP receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxamide spirohydantoin CGRP receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3833523